BioCentury
ARTICLE | Company News

7TM, JNJ asthma and allergy deal

June 9, 2005 1:00 AM UTC

7TM (Horsholm, Denmark) and Johnson & Johnson (JNJ) will discover antagonists of an undisclosed G protein-coupled receptor (GPCR) to treat asthma and allergy using 7TM's Site-Directed Drug Discovery p...